Results 81 to 90 of about 3,430 (196)
ABSTRACT The global administration of mRNA vaccines in response to the coronavirus disease 2019 (COVID‐19) pandemic has been crucial in mitigating the spread of the virus. While these vaccines are generally safe and effective, there have been occasional reports of rare adverse effects, including new‐onset nephropathies. Primary Sjögren's syndrome (pSS),
Chia‐Wei Tseng +3 more
wiley +1 more source
Anti-PLA2R antibody in primary and secondary forms of membranous glomerulopathy
INTRODUÇÃO: A glomerulopatia membranosa (GNM) é considerada a principal causa de síndrome nefrótica em adultos. A maioria dos casos é considerada primária, mas cerca de 20-30% das GNM são secundárias a uma condição clínica subjacente, como neoplasias ...
Gazeta, Cristina do Amaral [UNIFESP]
core
Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy
Lei Liu,1 Baochao Chang,1 Xueping Wu,1 Yaling Guo,1 Yan Pan,1 Lijuan Yang2 1Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Anhui, People’s Republic of China; 2Department of Physiology, Bengbu Medical College ...
Liu L +5 more
doaj
Nephrotic Syndrome: Beyond Common Causes
ABSTRACT We report the case of a 38‐year‐old Caucasian man with well‐controlled HIV on antiretroviral therapy who developed nephrotic syndrome. The patient presented with a maculopapular rash, lymphadenopathy, oral lesions, nasal congestion and bilateral pitting oedema. Laboratory tests revealed hypoalbuminemia, nephrotic range proteinuria and abnormal
Humam Hazim +4 more
wiley +1 more source
We present an interesting case where a patient with chronic hepatitis B infection develops antigenaemia and nephrotic syndrome, and subsequent pulmonary embolism, highlighting the intricate interplay between viral hepatitis, renal disease and hypercoagulability. ABSTRACT Hepatitis B is a major health concern.
Muhammad Hassaan Malik +4 more
wiley +1 more source
Background Since the emergence of the anti-PLA2R antibody (PLA2R-Ab) test, nephrology practice has not changed dramatically, with most nephrologists still relying on a kidney biopsy to diagnose membranous nephropathy.
Vilma Rautemaa +17 more
core +1 more source
Phospholipase A2 receptor 1 (PLA2R) is a target autoantigen in 70% of patients with idiopathic membranous nephropathy. We describe the location of a major epitope in the N-terminal cysteine-rich ricin domain of PLA2R that is recognized by 90% of human ...
Gummadova, Jennet +7 more
core +1 more source
Primary glomerular diseases and long‐term adverse health outcomes: A nationwide cohort study
Abstract Background Although glomerular diseases are the third most frequent cause of end‐stage kidney disease worldwide, little is known about their long‐term outcomes. Methods In patients with chronic kidney disease (CKD) stage 3–5 enrolled in the Swedish Renal Registry, we compared risks of hospitalization, kidney replacement therapy (KRT), major ...
Anne‐Laure Faucon +8 more
wiley +1 more source
Schematic of epitope spreading of PLA2R.
BackgroundM-type phospholipase A2 receptor (PLA2R) is the major autoantigen in adult idiopathic membranous nephropathy (IMN). Although reactive epitopes in the PLA2R domains have been identified, the clinical value of these domains recognized by anti ...
Yuan Qin (260617) +13 more
core +1 more source
International audienceBACKGROUND: Antibodies against M-type phospholipase A2 receptor (PLA2R) are serological markers of disease activity in patients with idiopathic membranous nephropathy (iMN).
Honsova, Eva +4 more
core +1 more source

